Abstract:Point-of-care sensors, which are low-cost and user-friendly, play a crucial role in precision medicine by providing quick results for individuals. Here, we transform the conventional glucometer into a 4-hydroxytamoxifen therapeutic biosensor in which 4-hydroxytamoxifen modulates the electrical signal generated by glucose oxidation. To encode the 4-hydroxytamoxifen signal within glucose oxidation, we introduce the ligand-binding domain of estrogen receptor-alpha into pyrroloquinoline quinone-dependent glucose dehydrogenase by constructing and screening a comprehensive protein insertion library. In addition to obtaining 4-hydroxytamoxifen regulatable engineered proteins, these results unveil the significance of both secondary and quaternary protein structures in propagation of conformational signals. By constructing an effective bioelectrochemical interface, we detect 4-hydroxytamoxifen in human blood samples as changes in the electrical signal and use this to develop an electrochemical algorithm to decode the 4-hydroxytamoxifen signal from glucose. To meet the miniaturization and signal amplification requirements for point-of-care use, we harness power from glucose oxidation to create a self-powered sensor. We also amplify the 4-hydroxytamoxifen signal using an organic electrochemical transistor, resulting in milliampere-level signals. Our work demonstrates a broad interdisciplinary approach to create a biosensor that capitalizes on recent innovations in protein engineering, electrochemical sensing, and electrical engineering.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a point - of - care therapeutics sensor based on a glucometer to achieve rapid, low - cost and user - friendly detection of specific biomarkers (such as 4 - hydroxytamoxifen, 4 - HT). Specifically, through protein engineering, electrochemical sensing and electronic integration technologies, the researchers transformed the traditional glucometer into a biosensor capable of detecting 4 - HT. The following are the key problems and solutions described in the paper: 1. **Background and Requirements**: - Existing point - of - care devices face many challenges when extracting information from blood, including the opacity of blood, chemical complexity and the presence of cells. - As a widely used point - of - care device, the glucometer has the advantages of low cost and simple operation, so it was selected as the object of transformation to meet various clinical analysis requirements. 2. **Research Objectives**: - Develop a glucometer - based allosteric sensor (GBAS) for electrochemical detection of specific biomarkers in blood and meet the miniaturization and signal amplification requirements of point - of - care testing. - Select 4 - HT as the target biomarker because it is a metabolite of tamoxifen, a drug widely used in the treatment of hormone - receptor - positive breast cancer. 3. **Key Technologies**: - **Protein Engineering**: An allosteric protein capable of responding to 4 - HT was constructed by inserting the ligand - binding domain (LBD) of estrogen receptor α into pyrroloquinoline quinone - dependent glucose dehydrogenase (PQQ - GDH). - **Electrochemical Sensing**: An electrochemical algorithm was designed to decode the 4 - HT signal, effectively reducing the interference caused by different glucose concentrations in the sample. - **Self - Powered Sensor**: The energy generated by glucose oxidation was used to power the sensor, eliminating the need for an external power source. - **Organic Electrochemical Transistor (OECT)**: By coupling the OECT with the self - powered sensor, signal amplification at the milliampere level was achieved, improving the detection sensitivity. 4. **Application Prospects**: - This sensor can not only rapidly detect 4 - HT, but also can be extended to the detection of other steroid - treating drugs, having broad application prospects, including doping control in sports medicine and monitoring of drug compliance. In summary, through innovative protein engineering and electrochemical sensing technologies, this research successfully transformed the traditional glucometer into an efficient point - of - care therapeutics sensor, solving the problem that existing detection devices are difficult to rapidly and accurately detect specific biomarkers in complex biological samples.

Creation of a point-of-care therapeutics sensor using protein engineering, electrochemical sensing and electronic integration

Point-of-care Testing of Protein Biomarkers by Integrating a Personal Glucose Meter with a Concatenated DNA Amplifier

A drug-mediated organic electrochemical transistor for robustly reusable biosensors

Blending Enzyme Immobilization Enabled High Performance Glucose Sensor Based on an n-channel Organic Electrochemical Transistor

Adaptable Xerogel-Layered Amperometric Biosensor Platforms on Wire Electrodes for Clinically Relevant Measurements

Electrochemical Biosensors for Point of care Applications

Towards Sensing of Breast Cancer Biomarkers: Engineering Glucose Dehydrogenase As an Estrogenic Regulated Protein

Development of a point-of-care colorimetric metabolomic sensor platform

A glucose meter interface for point-of-care gene circuit-based diagnostics

Mechanistic discoveries and simulation‐guided assay optimization of portable hormone biosensors with cell‐free protein synthesis

Advancing Point-of-Care Diagnostics of Metabolites Through Engineering Semisynthetic Proteins

Phosphorylcholine-Functionalized PEDOT-Gated Organic Electrochemical Transistor Devices for Ultra-Specific and Sensitive C-Reactive Protein Detection

A novel electrochemical microneedle sensor for highly sensitive real time monitoring of glucose

(Digital Presentation) Simultaneous and Real-Time Electrochemical Detection of Multiple Biomarkers in a Microfluidic Chip

Efficient Nanozyme-Triggered Pressure Sensor for Point-of-Care Immunoassay: Visual Sensing and Time Readout Device

Simple Electrochemical Sensing of Attomolar Proteins Using Fabricated Complexes with Enhanced Surface Binding Avidity

Real-time bioelectronic sensing of environmental contaminants

Automated and ultrasensitive point-of-care glycoprotein detection using boronate-affinity enhanced organic electrochemical transistor patch

Synthetic Circuit-Driven Expression of Heterologous Enzymes for Disease Detection

Microelectrical sensors as emerging platforms for protein biomarker detection in point-of-care diagnostics

An Electrochemical Biosensor Architecture Based on Protein Folding Supports Direct Real‐Time Measurements in Whole Blood